secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apogee Therapeutics, Inc. (APGE)
CIK:        0001974640
Form:       8-K
Filed at:   2026-06-12T21:01:14+00:00
Accession:  0001193125-26-269650
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Apogee shareholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting
--------------------------------------------------------------------------------

- Director nominees Mark C. McKenna, Jennifer Fox, William Jones elected with >44.9M votes each, broker non-votes 1.8M.
- Ratification of Ernst & Young as independent auditor for FY2026: 56.96M for, 1,361 against.
- Non-binding advisory vote on named executive officer compensation: 54.32M for, 634k against, 247k abstentions.
- All three proposals passed; no material changes to board composition or corporate governance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/apge-20260609.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-269650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer